Latest acquisition reinforces TEAM Tech’s leadership as the premier outsourced manufacturer of mission-critical medical devices

WASHINGTON & KNOXVILLE, Tenn.--(BUSINESS WIRE)--

Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government-regulated industries, today announced that its portfolio company TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, has acquired TAG3 Engineering, LLC (“TAG3” or the “Company”). The acquisition strengthens TEAM Tech’s design and development capabilities in the fastest growing medical device end markets, including therapeutic areas such as interventional cardiology and neurovascular. TAG3 is the third acquisition TEAM Tech has made within the first year of Arlington’s ownership.

TAG3 is a leading designer, developer and manufacturer of complex interventional medical devices, specializing in front-end design for innovative medical devices. The acquisition will complement TEAM Tech’s earlier acquisition of Duke Empirical (“Duke”), which specializes in the design and manufacturing of innovative catheters and minimally invasive delivery systems. The addition of TAG3 further expands TEAM Tech’s end-to-end offering, providing MedTech OEMs with a turnkey solution spanning from front-end design to commercial scale manufacturing.

Matt Altman, a Managing Partner at Arlington Capital Partners, said, “The acquisition of TAG3 further enhances TEAM Tech’s fast-growing minimally invasive surgical franchise. We are excited to partner with the exceptional TAG3 team to further support our healthcare customers from innovative design all the way through commercial production.”

Marshall White, President and CEO of TEAM Tech, said, “TAG3 is the perfect complement to our growing platform. Its front-end design expertise will accelerate the speed to market of mission-critical devices by seamlessly combining with the large scale commercialization capabilities of TEAM Tech. With these added capabilities, we are even better positioned to provide exceptional value to healthcare OEMs, and we are thrilled to welcome TAG3 to TEAM Tech.”

“TAG3 adds world-class design and development capabilities for complex Class II / III medical devices to TEAM Tech’s product portfolio along with expertise in advanced technologies including electrospinning, hydrophilic coatings and proprietary polymer blending,” said Gordon Auduong, a Managing Director at Arlington Capital Partners. “Together with Duke, TAG3 positions TEAM Tech as a true end-to-end partner in the most attractive medical device markets, accelerating speed to market for innovators building life-saving medical devices.”

Arlington has an extensive track record in the healthcare industry, where the firm helps to build leading businesses that save lives, improve the delivery of products and services and reduce costs for patients and providers. The firm’s recent healthcare investments include AVS Bio, Afton Scientific, Everest Clinical Research, Grand River Aseptic Manufacturing, Millstone Medical Outsourcing and Riverpoint Medical.

Solomon Partners served as financial advisor to TEAM Tech and Arlington. Bonifacio Consulting Services (BCS) served as operational advisor to TEAM Tech and Arlington.

About Arlington Capital Partners

Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 180 companies and has raised ~$14 billion in committed capital. For more information, visit Arlington’s website at www.arlingtoncap.com and follow Arlington on LinkedIn.

About TEAM Technologies

Headquartered in Knoxville, TN, with facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an extensive array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs. With its deep industry experience and reputation for the highest quality standards, TEAM Technologies leverages seamless, turnkey processes and innovation to dramatically simplify and improve its customers’ supply chains. For more information, visit teamtech.com.

About TAG3

TAG3 Engineering is a full-service MedTech design, development, and manufacturing partner, dedicated to driving innovation in the development of medical devices. With a focus on excellence and collaboration, TAG3 Engineering partners with medical device companies to accelerate design and development. TAG3 can tackle the full spectrum of needs that arise in all phases of the medical device lifecycle—from concept to commercialization. TAG3Engineering.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250916623043/en/

Source: Arlington Capital Partners